1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Mega-Fas-ligand: new trials by email Literature Review of Mega-Fas-ligand trials Research Report on Mega-Fas-ligand
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Pharmacokinetics of Rising Doses of APO010 in Relapsed/Refractory Multiple Myeloma Patients Selected by DRP APO010 - Relapsed/Refractory Multiple Myeloma | Phase 1 / Phase 2 | Terminated | Allarity Therapeutics | 1 | 2017-06-13 | 2020-01-30 |
| A Phase I Dose Finding Study of APO010 in Patients With Solid Tumors APO010 - Cancer | Phase 1 | Completed | Valerio Therapeutics | 26 | 2007-02-01 | 2015-09-17 |
Multiple Myeloma (1) · Neoplasms (1)
Allarity Therapeutics (1) · Valerio Therapeutics (1)
Denmark (1) · Switzerland (1)
Annette J Vangsted, DMSc (1) · Cristiana Sessa, Prof, MD (1)